Microsclerotherapy is the process used for the treatment of telangiectasia, which is characterized by broken blood vessels near the surface or mucous membrane appears as pink or red lines on the skin surface. A specialist injects a substance into the veins to treat varicose veins. The procedure uses a tiny needle to cause little discomfort. It is a highly effective method for eliminating veins in the legs, but it must be done at least two to six times for optimal results. The first session of microsclerotherapy will produce immediate results, although it may take 12 weeks for the effects to become fully apparent. The initial sessions may be painful. Simple analgesia is recommended. The treatment will take up to two years to completely disappear.
Microsclerotherapy involves injecting a solution called ‘sclerosant’ using microneedles. The process involves the injection of sclerosant in the affected veins, which destroys the endothelium, it triggers thrombosis followed by fibrosis and this results in the closing of the vessel. Sclerosant such as hypertonic saline solution, polidocanol, tetradecyl sulphate, and chromated glycerin are used in microsclerotherapy.
Genetic and environmental factors contribute to telangiectasia. Other factors that could cause telangiectasia are aging, pregnancy, rosacea, overexposure to sunlight, and varicose veins. There is no cure for this disorder, however, can be controlled by microsclerotherapy.
𝐑𝐞𝐜𝐞𝐢𝐯𝐞 𝐚 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/3372
Microsclerotherapy Treatment Market Drivers-
Key players are involved in development and commercialization of new sclerosants which would be used in the treatment of varicose veins such as hypertonic saline, sodium tetradecyl sulphate, and polidocanol is driving market growth. For instance, Medtronic Plc launched a new product, Venaceal closure system in U.S., in November 2015. The new product is non-invasive and uses a proprietary medical adhesive instead of a sclerosant to seal the varicose veins and is effective for patients suffering from varicose veins by removing the need for anesthesia, several injections, and use of compression stockings post operation, thus reducing the disadvantages caused by using sclerosants.
Moreover, in 2014, BTG international Inc. launched varithena (polidocanol) which decreases the symptoms, appearance of varicose veins as well as achiness, itching, and swelling of the veins. Furthermore, manufacturers are also focused on inorganic growth strategies such as mergers and acquisitions. For instance, in August 2019, Boston Scientific acquired BTG International, Inc as BTG manufactures and commercialize products used in minimally invasive treatments used for targeting cancer and other vascular diseases.
According the National Center for Biotechnology Information (NCBI), 2019, 41% people in the U.S. suffer from varicose veins and around 41% of women population and 50% of the men population all over the world, over the age of 50 have telangiectasia. According to NCBI, 2018, lower limb varicose veins are very common and over 10 – 30% of the world wide population suffers from telangiectasia. During the onset of periods and pregnancy, most of the women are prone to telangiectasia. Other reasons are standing and sitting for long periods of time, sitting cross legged, obesity, and others. Growing incidence of telangiectasia is projected to boost the global microsclerotherapy treatment market growth in the near future.
Global Microsclerotherapy Treatment Market Restraints
Side effects and high treatment costs are projected to hinder the global microsclerotherapy treatment market growth. According to the Journal of Phelbolymphology (2017), around 1-10% patients reported matting and residual pigmentation as complications post microsclerotherapy treatment. The treatments are expensive, ranging from, US$ 600 to US$ 1,200, and the cost is dependent upon the size of the vein and at least 2 to 6 treatment sessions are required with the interval of 4 to 6 weeks. The procedure is a little painful while compression bandage is to be worn post operation for several weeks which can be uncomfortable to the patients.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/3372
Global Microsclerotherapy Treatment Market Regional Analysis-
High incidences of telangiectasia has been recorded in the Western Countries such as Europe, America and Australia and this disorder is most commonly observed in females as compared to males. According to the International Journal of Pharmaceutical Sciences and Research, (2018), High prevalence of varicose veins has been recorded in U.S, Europe and some parts of Australia. According to the same source, one third of the population worldwide is suffering from varicose veins, out of which, around 73% females (especially during pregnancy) and 56% males are suffering from varicose veins.
Most of the manufacturer’s headquarters are located in U.S. and Europe like QOL Medical LLC, Mckesson Corporation, Kreussler, Inc, and Teleflex Incorporated and Boston Scientific Corporation. Thus, launch of existing as well as new treatment options across North America and Europe is projected to augment the global microsclerotherapy treatment market growth over the forecast period.
Global Microsclerotherapy Treatment Market Key Players-
Key players operating in the global microsclerotherapy treatment market are Surgimedix, Inc., Merz Pharma GmbH & Co. KGaA, QOL Medical LLC, McKesson Corporation, Kreussler, Inc., Provensis, ltd, STD Pharmaceuticals Product Ltd., Medtronic plc, Teleflex Incorporated, and Boston Scientific Corporation.
By Products Type–
- Sclerosant Type
- Detergent Based –
- Sodium Tetradecyl Sulphate
- Ethanolamine Oleate
- Chemical Based –
- Chromated Glycerine
- Osmotic Agents –
- Hypertonic Saline or Hypertonic Glucose
By End Users-
- Aesthetic Treatment Clinics
- North America
- Latin America
- Asia Pacific
- Middle East
If you have any special requirements, please let us know and we will offer you the report as you want.
𝐖𝐞 𝐎𝐟𝐟𝐞𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐂𝐥𝐢𝐜𝐤 @ https://www.coherentmarketinsights.com/insight/request-customization/3372
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Microsclerotherapy Treatment Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Microsclerotherapy Treatment Industry Impact
Chapter 2 Microsclerotherapy Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Microsclerotherapy Treatment (Volume and Value) by Type
2.3 Microsclerotherapy Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Microsclerotherapy Treatment Sales, Consumption, Export, Import by Regions
Chapter 5 North America Microsclerotherapy Treatment Market Analysis
Chapter 6 East Asia Microsclerotherapy Treatment Market Analysis
Chapter 7 Europe Microsclerotherapy Treatment Market Analysis
Chapter 8 South Asia Microsclerotherapy Treatment Market Analysis
Chapter 9 Southeast Asia Microsclerotherapy Treatment Market Analysis
Chapter 10 Middle East Microsclerotherapy Treatment Market Analysis
Chapter 11 Africa Microsclerotherapy Treatment Market Analysis
Chapter 12 Oceania Microsclerotherapy Treatment Market Analysis
Chapter 13 South America Microsclerotherapy Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Microsclerotherapy Treatment Business
Chapter 15 Microsclerotherapy Treatment Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027